Every developing story NewsAI is tracking for weight-loss drugs — as timelines, not a pile of articles.
Experts say any short-term financial benefit will be outweighed by long-term health costs related to obesity Faced with high demand for GLP-1 drugs, some American cities and…
India could soon get a lot thinner - at least in theory. On Friday the patent on semaglutide - the molecule behind Danish drugmaker Novo Nordisk's blockbuster weight-loss drugs…
The most recent articles mentioning weight-loss drugs, grouped by month. Open a story above to read it as a full timeline.
Experts say any short-term financial benefit will be outweighed by long-term health costs related to obesity Faced with high demand for GLP-1 drugs, some American cities and…
India could soon get a lot thinner - at least in theory. On Friday the patent on semaglutide - the molecule behind Danish drugmaker Novo Nordisk's blockbuster weight-loss drugs…
